Aravive (STU:VE11) Non Operating Income : €16.44 Mil (TTM As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Aravive Non Operating Income?

Non Operating Income is income or expense that comes from miscellaneous sources. Aravive's Non Operating Income for the three months ended in Sep. 2023 was €28.05 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Sep. 2023 was €16.44 Mil.

Aravive Non Operating Income Historical Data

The historical data trend for Aravive's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aravive Non Operating Income Chart

Aravive Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Non Operating Income

Get a 7-Day Free Trial

-33.22

2.28

-4.77

1.29

-5.79

Aravive Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Non Operating Income	Get a 7-Day Free Trial															0.75	-9.15	-30.36	27.91	28.05

Aravive Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €16.44 Mil.

Aravive Non Operating Income Related Terms

Thank you for viewing the detailed overview of Aravive's Non Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Aravive (STU:VE11) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aravive Inc (STU:VE11) » Definitions » Non Operating Income

Comparable Companies

Traded in Other Exchanges

ARAV:USA VE11:Germany

Address

3730 Kirby Drive, River Oaks Tower, Suite 1200, Houston, TX, USA, 77098

Website

https://www.aravive.com

Aravive Inc is a clinical-stage biopharmaceutical company. It focuses on developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis. The company pipeline product Batiraxcept (formerly AVB-500) which is an ultra-high affinity decoy protein that binds to GAS6 and thereby prevents AXL signaling to inhibit metastasis and tumor growth and restore sensitivity to anti-cancer agents. Batiraxcept is currently being evaluated in multiple clinical trials.

Aravive (STU:VE11) Headlines

No Headlines